The Development of Bilateral Mastoiditis Following Acute Otitis Media in a Pediatric Patient with Limited Access to Health Care.
| Autor: | Telatin M; Medical School, Nova Southeastern University, Dr. Kiran C. Patel College of Osteopathic Medicine, Davie, USA., Irvine DS; Medical School, Nova Southeastern University, Dr. Kiran C. Patel College of Osteopathic Medicine, Davie, USA., Kesselman MM; Rheumatology, Nova Southeastern University, Dr. Kiran C. Patel College of Osteopathic Medicine, Davie, USA., Cullen JM; Family and Community Medicine, Community Health Center of West Palm Beach, West Palm Beach, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Feb 17; Vol. 15 (2), pp. e35113. Date of Electronic Publication: 2023 Feb 17 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.35113 |
| Abstrakt: | Infection of the mastoid cells, known as mastoiditis, can develop due to untreated otitis media, in which bacteria colonize the mastoid air cells that line the inner and middle ear. Antibiotic therapy for otitis media has made the development of mastoiditis a very rare occurrence. However, despite its low prevalence, it is important to keep this complication in mind when treating otitis media in the pediatric population due to the increased susceptibility of mastoiditis in this demographic. Furthermore, pediatric patients of lower socioeconomic status who have limited access to health care may be at an even greater risk for the development of mastoiditis. We report a case of a pediatric patient with significant barriers to health care who developed bilateral mastoiditis as a complication of otitis media, requiring hospitalization and intravenous antibiotic therapy. The patient also experienced hearing loss as a sequela of the infection. Improved access to medical care, parent or guardian education on how to recognize primary otitis media infections, and the use of adequate antibiotic therapy when indicated can effectively prevent the development of mastoiditis following otitis media infections among patients. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Telatin et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|